Personalised Medicine the evolution of healthcare for improving people s lives
The project PM4Future aims at organising a Conference on Personalised Medicine with the overarching objective of identifying challenges and opportunities for the implementation of personalised medicine in the healthcare as well as...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
ERA PerMed
ERA Net Cofund in Personalised Medicine
32M€
Cerrado
EP PerMed
European Partnership for Personalised Medicine
335M€
Cerrado
ERDERA
EUROPEAN RARE DISEASES RESEARCH ALLIANCE
146M€
Cerrado
EMERALD
International PhD Programme for Medical Doctors
5M€
Cerrado
PRECeDI
Personalized PREvention of Chronic DIseases
792K€
Cerrado
EU-Africa PerMed
BUILDING LINKS BETWEEN EUROPE AND AFRICA IN PERSONALISED MED...
2M€
Cerrado
Información proyecto PM4Future
Duración del proyecto: 5 meses
Fecha Inicio: 2023-07-04
Fecha Fin: 2023-12-31
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
The project PM4Future aims at organising a Conference on Personalised Medicine with the overarching objective of identifying challenges and opportunities for the implementation of personalised medicine in the healthcare as well as gaps on research and funding. The event, organised by the Spanish Foundation for Science and Technology (FECYT), on behalf of the Spanish Ministry of Science and Innovation (MCIN) and with collaboration of the Institute of Health Carlos III (ISCIII), the Centre for the Development of Technology and Innovation (CDTI), will be held on October the 4th and 5th 2023 in Valencia.
The agenda will focus on three main axes: 1) Prevention, diagnostics and treatment of diseases through a personalised approach; 2) Tools for Personalised Medicine: the role of federated transnational research infrastructures in the research and development of PM; and 3) International cooperation as an element to promote the development of Personalised medicine in African and Latin American regions.